2025. Dupilumab-Treated Patients With Prurigo Nodularis Report Disease Control and Treatment Satisfaction: 6-Month Results From the RELIEVE-PN Study. SKIN The Journal of Cutaneous Medicine. 9, 6 (Nov. 2025), s716. DOI:https://doi.org/10.25251/h522p595.